Apellis Pharmaceuticals (APLS) files automatic mixed securities shelf
Tweet
Share
E-mailGet Alerts APLS Hot Sheet
Join SI Premium – FREE
Apellis Pharmaceuticals (NASDAQ: APLS) files automatic mixed securities shelf
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Reiterates Buy Rating on Apellis Pharmaceuticals (APLS)
- Hemostemix closes second tranche, raises CDN$322,250
- Apnimed prices IPO at $16 per share, raising $192 million
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
